Literature DB >> 31299445

Psychological burden of PTSD, depression, and their comorbidity in the U.S. veteran population: Suicidality, functioning, and service utilization.

Brandon Nichter1, Sonya Norman2, Moira Haller3, Robert H Pietrzak4.   

Abstract

BACKGROUND: Emerging evidence suggests that comorbid posttraumatic stress disorder (PTSD) and major depressive disorder (PTSD/MDD) may impose an even greater burden than either disorder alone. However, nearly all previous studies examining these associations have relied on treatment-seeking samples. This study examined the mental health burden associated with co-occurring PTSD/MDD compared to PTSD and MDD alone using a nationally representative sample of U.S. veterans.
METHODS: Data were analyzed from National Health and Resilience in Veterans Study, a nationally representative survey of U.S. veterans (n = 2,732). Analyses (a) estimated the current prevalence of PTSD only, MDD only, and comorbid PTSD/MDD; (b) compared demographic/military variables by PTSD/MDD status; and (c) examined associations between PTSD/MDD status and suicidality, functioning, psychiatric comorbidities, and service utilization.
RESULTS: The current prevalences of probable PTSD only, probable MDD only, and probable comorbid PTSD/MDD were 1.7%, 4.8%, and 3.4%. Compared to all other groups, the PTSD/MDD group was more likely to screen positive for current suicidal ideation, lifetime suicide attempts, probable generalized anxiety and social anxiety disorders, and ever utilize mental health services. They also scored lower on measures of mental health functioning (d = 1.49), cognitive functioning (d = 1.03), and quality of life (d = 0.84). Veterans with comorbid PTSD/MDD were more than twice as likely as those with PTSD only to have attempted suicide. LIMITATIONS: The cross-sectional design of this study precludes causal inference.
CONCLUSIONS: Results provide a population-based characterization of the psychological burden of PTSD/MDD comorbidity in U.S. veterans. Findings further underscore the importance of screening, monitoring, and treatment of the comorbid manifestation of these disorders. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2019        PMID: 31299445     DOI: 10.1016/j.jad.2019.06.072

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  17 in total

Review 1.  The National Health and Resilience in Veterans Study: A Narrative Review and Future Directions.

Authors:  Brienna M Fogle; Jack Tsai; Natalie Mota; Ilan Harpaz-Rotem; John H Krystal; Steven M Southwick; Robert H Pietrzak
Journal:  Front Psychiatry       Date:  2020-12-09       Impact factor: 4.157

Review 2.  Annual Research Review: Defining and treating pediatric treatment-resistant depression.

Authors:  Jennifer B Dwyer; Argyris Stringaris; David A Brent; Michael H Bloch
Journal:  J Child Psychol Psychiatry       Date:  2020-02-04       Impact factor: 8.982

Review 3.  MicroRNAs as biomarker and novel therapeutic target for posttraumatic stress disorder in Veterans.

Authors:  Sudhiranjan Gupta; Rakeshwar S Guleria; Yvette Z Szabo
Journal:  Psychiatry Res       Date:  2021-10-26       Impact factor: 3.222

4.  Amputation-specific and generic correlates of participation among Veterans with lower limb amputation.

Authors:  Christopher R Erbes; John Ferguson; Kalia Yang; Sara Koehler-McNicholas; Melissa A Polusny; Brian J Hafner; Allen W Heinemann; Jessica Hill; Tonya Rich; Nicole Walker; Marilyn Weber; Andrew Hansen
Journal:  PLoS One       Date:  2022-07-07       Impact factor: 3.752

5.  Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series.

Authors:  Hewa Artin; Sean Bentley; Eamonn Mehaffey; Fred X Liu; Kevin Sojourner; Andrew W Bismark; David Printz; Ellen E Lee; Brian Martis; Sharon De Peralta; Dewleen G Baker; Jyoti Mishra; Dhakshin Ramanathan
Journal:  EClinicalMedicine       Date:  2022-05-06

6.  The role of oxytocin signaling in depression and suicidality in returning war veterans.

Authors:  Corinne D Warrener; Edward M Valentin; Camilla Gallin; Lynnet Richey; Deanna B Ross; Chelsea J Hood; Adriana Lori; Joseph Cubells; Sheila A M Rauch; James K Rilling
Journal:  Psychoneuroendocrinology       Date:  2020-12-24       Impact factor: 4.905

7.  Systematic Review and Methodological Considerations for the Use of Single Prolonged Stress and Fear Extinction Retention in Rodents.

Authors:  Chantelle Ferland-Beckham; Lauren E Chaby; Nikolaos P Daskalakis; Dayan Knox; Israel Liberzon; Miranda M Lim; Christa McIntyre; Shane A Perrine; Victoria B Risbrough; Esther L Sabban; Andreas Jeromin; Magali Haas
Journal:  Front Behav Neurosci       Date:  2021-05-14       Impact factor: 3.558

8.  Hippocampal Resting-State Functional Connectivity Forecasts Individual Posttraumatic Stress Disorder Symptoms: A Data-Driven Approach.

Authors:  Jacklynn M Fitzgerald; Elisabeth Kate Webb; Carissa N Weis; Ashley A Huggins; Ken P Bennett; Tara A Miskovich; Jessica L Krukowski; Terri A deRoon-Cassini; Christine L Larson
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-09-01

9.  Presence of PTSD is Associated with Clinical and Functional Impact in Veterans with Depression Treated in Community-Based Clinics.

Authors:  Fenan S Rassu; Shubhada Sansgiry; Natalie E Hundt; Mark E Kunik; Jeffrey A Cully
Journal:  J Clin Psychol Med Settings       Date:  2021-06-22

10.  Psychiatric comorbidity of developmental trauma disorder and posttraumatic Stress disorder: findings from the DTD field trial replication (DTDFT-R).

Authors:  Julian D Ford; Joseph Spinazzola; Bessel van der Kolk
Journal:  Eur J Psychotraumatol       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.